Neuroprotective Substances: Are they Able to Protect the Pancreatic Beta- Cells Too?
- 1 July 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 22 (8) , 834-841
Abstract
Background: Growing pieces of evidence demonstrate a close relationship between type 2 diabetes (T2D) and neurodegenerative disorders such as Alzheimer’s disease. The similarity of physiological and pathological processes occurring in pancreatic β-cells and neurons over the course of these pathologies allows raising the question of the practicability of studying neuroprotective substances for their potential antidiabetic activity.Objective: This review analyzes studies of antidiabetic and cytoprotective action on pancreatic β-cells of the neuroprotective compounds that can attenuate the oxidative stress and enhance the expression of neurotrophins: low-molecular-weight NGF mimetic compound GK-2, selective anxiolytic afobazole, antidepressants lithium chloride, and lithium carbonate on the rat streptozotocin model of T2D.Results: It was found that all the above-listed neuroprotective substances have a pronounced antidiabetic activity. The decrease in the β-cells number, the average area of the pancreatic islets, as well as the violation of their morphological structure caused by the streptozotocin was significantly weakened by the therapy with the investigated neuroprotective substances. The extent of these morphological changes clearly correlates with the antihyperglycemic effect of these compounds.Conclusion: The presented data indicate that the neuroprotective substances attenuating the damaging effect of oxidative stress and neurotrophins deficit cannot only protect neurons but also exert their cytoprotective effect towards pancreatic β-cells. These data may provide a theoretical basis for the further study of neuroprotective drugs as potential therapeutic options for T2D prevention and treatment.Keywords
This publication has 74 references indexed in Scilit:
- Diabetes and Overexpression of proNGF Cause Retinal Neurodegeneration via Activation of RhoA PathwayPLOS ONE, 2013
- β‐Cell evolution: How the pancreas borrowed from the brainBioEssays, 2011
- Fasting Blood Glucose and Depressive Mood among Patients with Mental Illness in a Medicaid Managed Care ProgramDepression Research and Treatment, 2011
- The lighter side of BDNFAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Hypoxia-inducible factor-1α regulates β cell function in mouse and human isletsJournal of Clinical Investigation, 2010
- Oxygen Tension Regulates Pancreatic β-Cell Differentiation Through Hypoxia-Inducible Factor 1αDiabetes, 2009
- Interaction of Afobazole with σ1-ReceptorsBulletin of Experimental Biology and Medicine, 2009
- Gene regulatory factors in pancreatic developmentDevelopmental Dynamics, 2003
- Expression of Nerve Growth Factor in Human Pancreatic β CellsGrowth Factors, 2003
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990